- Home
- LPCN vs IHT Comparison
LPCN vs IHT Comparison
Compare LPCN & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- IHT
- Stock Information
- Founded
- LPCN 1997
- IHT 1971
- Country
- LPCN United States
- IHT United States
- Employees
- LPCN N/A
- IHT N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- LPCN Health Care
- IHT Finance
- Exchange
- LPCN Nasdaq
- IHT Nasdaq
- Market Cap
- LPCN 16.1M
- IHT 19.0M
- IPO Year
- LPCN N/A
- IHT N/A
- Fundamental
- Price
- LPCN $2.95
- IHT $2.00
- Analyst Decision
- LPCN Strong Buy
- IHT
- Analyst Count
- LPCN 2
- IHT 0
- Target Price
- LPCN $9.00
- IHT N/A
- AVG Volume (30 Days)
- LPCN 36.3K
- IHT 6.2K
- Earning Date
- LPCN 08-05-2025
- IHT 09-15-2025
- Dividend Yield
- LPCN N/A
- IHT 1.00%
- EPS Growth
- LPCN N/A
- IHT N/A
- EPS
- LPCN N/A
- IHT N/A
- Revenue
- LPCN $4,208,119.00
- IHT $7,505,309.00
- Revenue This Year
- LPCN N/A
- IHT N/A
- Revenue Next Year
- LPCN N/A
- IHT N/A
- P/E Ratio
- LPCN N/A
- IHT N/A
- Revenue Growth
- LPCN N/A
- IHT N/A
- 52 Week Low
- LPCN $2.68
- IHT $1.52
- 52 Week High
- LPCN $6.17
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- LPCN 37.54
- IHT 44.46
- Support Level
- LPCN $2.92
- IHT $1.94
- Resistance Level
- LPCN $3.25
- IHT $2.25
- Average True Range (ATR)
- LPCN 0.19
- IHT 0.16
- MACD
- LPCN -0.04
- IHT -0.00
- Stochastic Oscillator
- LPCN 4.41
- IHT 51.72
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.